BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CTCF, P49711, 10664, ENSG00000102974 AND Prognosis
7 results:

  • 1. Differential DNA methylation and ctcf binding between the ESR1 promoter a of MCF-7 and MDA-MB-231 breast cancer cells.
    Montes-de-Oca-Fuentes EV; Jácome-López K; Zarco-Mendoza A; Guerrero G; Ventura-Gallegos JL; Juárez-Méndez S; Cabrera-Quintero AJ; Recillas-Targa F; Zentella-Dehesa A
    Mol Biol Rep; 2024 Jan; 51(1):148. PubMed ID: 38236307
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein.
    Cai Z; Shi Q; Li Y; Jin L; Li S; Wong LL; Wang J; Jiang X; Zhu M; Lin J; Wang Q; Yang W; Liu Y; Zhang J; Gong C; Yao H; Yao Y; Liu Q
    Sci Adv; 2023 Oct; 9(40):eadi3821. PubMed ID: 37801505
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.
    Zhang L; Sun S; Zhao X; Liu J; Xu Y; Xu L; Song C; Li N; Yu J; Zhao S; Yu P; Fang F; Xie J; Ji X; Yu R; Ou Q; Zhao Z; Li M
    Mol Oncol; 2022 Oct; 16(20):3689-3702. PubMed ID: 35971249
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer.
    Sun G; Wang C; Wang S; Sun H; Zeng K; Zou R; Lin L; Liu W; Sun N; Song H; Liu W; Zhou T; Jin F; Shan Z; Zhao Y
    Nucleic Acids Res; 2020 Nov; 48(19):10768-10784. PubMed ID: 32986841
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in cancer.
    Xu S; Wang Q; Kang Y; Liu J; Yin Y; Liu L; Wu H; Li S; Sui S; Shen M; Zheng W; Pang D
    Cancer Immunol Res; 2020 Jul; 8(7):937-951. PubMed ID: 32321773
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer.
    Dutertre M; Gratadou L; Dardenne E; Germann S; Samaan S; Lidereau R; Driouch K; de la Grange P; Auboeuf D
    Cancer Res; 2010 May; 70(9):3760-70. PubMed ID: 20406972
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Decreased poly(ADP-ribosyl)ation of ctcf, a transcription factor, is associated with breast cancer phenotype and cell proliferation.
    Docquier F; Kita GX; Farrar D; Jat P; O'Hare M; Chernukhin I; Gretton S; Mandal A; Alldridge L; Klenova E
    Clin Cancer Res; 2009 Sep; 15(18):5762-71. PubMed ID: 19737964
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.